Given that CD4+ T cells isolated from tumor tissue were enriched for Tregs, we hypothesized that the ratio of Tregs to Th in tumors would correlate with the capacity of the resultant DCs to induce FoxP3+ Tregs. The gene discussed is CD4; the disease is neoplasm.